Status | Study |
RECRUITING |
Study Name: A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2024-02-26 Interventions: Whether lymph nodes dissection should be performed on curative-intent hepatectomy for intrahepatic cholangiocarcinoma is still debated. |
Completed |
Study Name: HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2022-08-04 Interventions: Procedure: hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)FOLFOX-HAIC as the following dosag |
RECRUITING |
Study Name: PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients With Intrahepatic Cholangiocarcinoma After Surgery Condition: Intrahepatic Cholangiocarcinoma Date: 2020-03-02 Interventions: PD1 antibody SHR-1210 D1 200 mg every three weeks; Three weeks is a course of treatment with a total of 8 courses, or the patient has tumor recurrence |
Not yet recruiting |
Study Name: Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma Condition: Bile Duct Cancer Intrahepatic Cholangiocarcinoma Date: 2017-03-13 Interventions: Combination Product: Melphalan/HDS |
Not yet recruiting |
Study Name: A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2017-02-09 Interventions: Drug: Carboplatin Arm A: Carbo |
Not yet recruiting |
Study Name: A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma Condition: Unresectable Intrahepatic Cholangiocarcinoma Date: 2016-12-06 Interventions: Drug: gemcitabine 1000 mg/m^2 |
Not yet recruiting |
Study Name: Liver Transplantation for Early Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2016-08-17 Interventions: Procedure: Deceased donor Liver Transplantation Deceased donor orthotopic liver transplantation |
Withdrawn |
Study Name: Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery Condition: Bile Duct Adenocarcinoma Stage III Intrahepatic Cholangiocarcinoma Date: 2016-07-27 Interventions: Drug: Capecitabine Given PO |
Recruiting |
Study Name: SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma Condition: Intrahepatic Cholangiocarcinoma Date: 2016-05-13 Interventions: Drug: Cisplatin-gemcitabine Sy |
Active, not recruiting |
Study Name: Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples Condition: Intrahepatic Cholangiocarcinoma Mixed Hepatocellular Cholangioc Date: 2016-05-02 |